Browse by author
Lookup NU author(s): Dr Anand Dixit
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2012 World Stroke Organization. Background: Estimates of neuronal loss in acute ischemic stroke show that the typical patient may lose 1·9million neurons each minute that treatment is delayed. Consequently, significant emphasis has been placed on early evaluation and thrombolysis with tissue plasminogen activator (TPA), the only approved thrombolytic therapy. TPA should be administered as a bolus followed by an immediate infusion because of its short half life. However, in the real life clinical situation, delays in starting the infusion after the bolus can occur. Similarly, once infusion has started, interruptions in the infusion of TPA can also occur. These scenarios may result in lower serum concentrations which could decrease the effectiveness of thrombolysis. We sought to simulate, the influence of bolus infusion delays and also the influence of different intervals of interruptions in the infusion of TPA on serum TPA concentrations. Methods: We simulated the effect of multiple intervals of delay after the bolus on serum TPA concentrations using known pharmacokinetics parameters of TPA. The effect of different intervals of interruptions in the infusion of TPA was also determined. The effect of rebolusing with TPA on serum concentrations in the event of significant bolus to infusion delays or significant infusion interruption was also simulated. Results: Our data show that delays in starting the infusion may have significant effects on serum TPA concentrations. After the initial bolus, there is a rapid decrease in serum TPA concentrations unless the infusion is started immediately. Greater than 5min delays in starting the infusion results in a slow gradual increase in serum TPA levels and levels stay well below the target concentrations for significant periods of time. Similarly, interruptions in the infusion of TPA lasting longer than 5min can also significantly influence TPA levels. Rebolusing with TPA in these scenarios rapidly restores TPA levels to target concentrations. Conclusion: Because of its short half life, TPA should be administered as a bolus followed by an immediate infusion. Bolus to infusion delays or interruptions in the infusion of TPA after the bolus may significantly impact serum TPA levels and may reduce the efficacy of thrombolysis. Protocols or administration regimens should be employed to prevent delays or interruptions in the infusion. When delays do occur, rebolusing of TPA may be needed to rapidly restore TPA to target levels.
Author(s): Smith C, Al-Nuaimi Y, Wainwright J, Sherrington C, Singh A, Kallingal J, Douglass C, Parry-Jones A, Smith C, Dixit A, Majid A
Publication type: Article
Publication status: Published
Journal: International Journal of Stroke
Year: 2014
Volume: 9
Issue: 7
Pages: 939-942
Print publication date: 01/10/2014
Online publication date: 04/12/2012
Acceptance date: 17/05/2012
ISSN (print): 1747-4930
ISSN (electronic): 1747-4949
Publisher: Sage Publications Ltd
URL: https://doi.org/10.1111/j.1747-4949.2012.00924.x
DOI: 10.1111/j.1747-4949.2012.00924.x
PubMed id: 23205632
Altmetrics provided by Altmetric
